Leatt Corp - Quarter Report: 2014 September (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 10−Q
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended: September 30, 2014
[_] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____________to _____________
Commission File No. 000-54693
LEATT CORPORATION
(Exact name
of registrant as specified in its charter)
Nevada | 20-2819367 |
(State or other jurisdiction of incorporation or | (I.R.S. Employer Identification No.) |
organization) |
50 Kiepersol Drive, Atlas Gardens, Contermanskloof Road,
Durbanville, Western Cape, South Africa, 7441
(Address of
principal executive offices)
+(27)
21-557-7257
(Registrants telephone
number, including area code)
__________________________________________________________________
(Former
name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes [X] No [_]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes [X] No [_]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer [_] | Accelerated filer [_] |
Non-accelerated filer (Do not check if a smaller reporting company) [_] | Smaller reporting company [X] |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes [_] No [X]
The number of shares outstanding of each of the issuers classes of common stock, as of November 10, 2014 is as follows:
Class of Securities | Shares Outstanding |
Common Stock, $0.001 par value | 5,200,623 |
LEATT CORPORATION
Quarterly Report on Form 10-Q
Three and
Nine Months Ended September 30, 2014
TABLE OF CONTENTS
PART I | 1 | |
FINANCIAL INFORMATION | 1 | |
ITEM 1. | FINANCIAL STATEMENTS. | 1 |
ITEM 2. | MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. | 11 |
ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. | 21 |
ITEM 4. | CONTROLS AND PROCEDURES. | 21 |
PART II | 21 | |
OTHER INFORMATION | 21 | |
ITEM 1. | LEGAL PROCEEDINGS. | 21 |
ITEM 1A. | RISK FACTORS. | 22 |
ITEM 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS. | 22 |
ITEM 3. | DEFAULTS UPON SENIOR SECURITIES. | 22 |
ITEM 4. | MINE SAFETY DISCLOSURES. | 22 |
ITEM 5. | OTHER INFORMATION. | 22 |
ITEM 6. | EXHIBITS. | 23 |
i
PART I
FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS.
LEATT CORPORATION
CONSOLIDATED FINANCIAL
STATEMENTS
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2014 AND
2013
Page(s) | |
Financial Statements | |
Consolidated Balance Sheets | 2 |
Consolidated Statements of Operations and Comprehensive Loss | 3 |
Consolidated Statement of Changes in Stockholders' Equity | 4 |
Consolidated Statements of Cash Flows | 5 |
Notes to Consolidated Financial Statements | 6 - 7 |
- 1 -
LEATT CORPORATION
CONSOLIDATED BALANCE SHEETS
ASSETS
September 30, 2014 | December 31, 2013 | |||||
Unaudited | Audited | |||||
Current Assets | ||||||
Cash and cash equivalents | $ | 820,371 | $ | 835,012 | ||
Short-term investments | 58,147 | 58,130 | ||||
Accounts receivable | 1,464,776 | 3,139,273 | ||||
Inventory | 3,123,104 | 3,259,274 | ||||
Payments in advance | 395,239 | 144,302 | ||||
Income tax refunds receivable | 25,299 | 299 | ||||
Deferred tax asset | 110,000 | 110,000 | ||||
Prepaid expenses and other current assets | 382,117 | 1,092,450 | ||||
Total current assets | 6,379,053 | 8,638,740 | ||||
Property and equipment, net | 834,482 | 891,728 | ||||
Other Assets | ||||||
Other receivables | 240,000 | 330,000 | ||||
Deposits | 16,893 | 19,469 | ||||
Intangible assets | 83,795 | 89,960 | ||||
Total other assets | 340,688 | 439,429 | ||||
Total Assets | $ | 7,554,223 | $ | 9,969,897 | ||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||
Current Liabilities | ||||||
Accounts payable and accrued expenses | $ | 1,183,727 | $ | 2,076,809 | ||
Short-term loan, net of finance charges | 36,187 | 833,735 | ||||
Total current liabilities | 1,219,914 | 2,910,544 | ||||
Deferred tax liabilities | 40,300 | 40,680 | ||||
Commitments and contingencies | ||||||
Stockholders' Equity | ||||||
Preferred stock, $.001 par value, 1,120,000 shares authorized, 120,000 shares issued and outstanding | 3,000 | 3,000 | ||||
Common stock, $.001 par value, 28,000,000 shares authorized, 5,200,623 shares issued and outstanding | 130,008 | 130,008 | ||||
Additional paid - in capital | 7,309,942 | 7,307,515 | ||||
Accumulated other comprehensive loss | (205,044 | ) | (111,864 | ) | ||
Accumulated deficit | (943,897 | ) | (309,986 | ) | ||
Total stockholders' equity | 6,294,009 | 7,018,673 | ||||
Total Liabilities and Stockholders' Equity | $ | 7,554,223 | $ | 9,969,897 |
See accompanying notes to consolidated financial statements
- 2 -
LEATT CORPORATION
CONSOLIDATED STATEMENTS OF
OPERATIONS AND COMPREHENSIVE LOSS
Three Months Ended | Nine Months Ended | |||||||||||
September 30, | September 30, | |||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||
Unaudited | Unaudited | Unaudited | Unaudited | |||||||||
Revenues |
$ | 3,468,761 | $ | 2,243,598 | $ | 11,159,630 | $ | 9,108,243 | ||||
|
||||||||||||
Cost of Revenues |
1,584,460 | 1,071,522 | 5,070,624 | 4,555,276 | ||||||||
|
||||||||||||
Gross Profit |
1,884,301 | 1,172,076 | 6,089,006 | 4,552,967 | ||||||||
|
||||||||||||
Product Royalty Income |
65,083 | 105,328 | 136,346 | 285,014 | ||||||||
|
||||||||||||
Operating Expenses |
||||||||||||
Salaries and wages |
547,955 | 508,641 | 1,651,178 | 1,640,282 | ||||||||
Commissions and consulting expenses |
134,692 | 142,866 | 441,943 | 426,035 | ||||||||
Professional fees |
209,168 | 197,672 | 823,690 | 1,013,783 | ||||||||
Advertising and marketing |
320,449 | 339,578 | 995,502 | 1,069,903 | ||||||||
Office rent and expenses |
61,807 | 62,528 | 183,792 | 195,342 | ||||||||
Research and development costs |
288,904 | 274,218 | 903,231 | 839,823 | ||||||||
Bad debt expense |
16,357 | - | 38,652 | - | ||||||||
General and administrative expenses |
565,004 | 518,537 | 1,611,242 | 1,619,221 | ||||||||
Depreciation |
67,075 | 60,585 | 214,583 | 252,040 | ||||||||
Total operating expenses |
2,211,411 | 2,104,625 | 6,863,813 | 7,056,429 | ||||||||
|
||||||||||||
Loss from Operations |
(262,027 | ) | (827,221 | ) | (638,461 | ) | (2,218,448 | ) | ||||
|
||||||||||||
Other Income (Expense) |
||||||||||||
Interest and other income (expense), net |
(914 | ) | 4,505 | 4,680 | 5,647 | |||||||
Total other income (expense) |
(914 | ) | 4,505 | 4,680 | 5,647 | |||||||
|
||||||||||||
Loss Before Income Taxes |
(262,941 | ) | (822,716 | ) | (633,781 | ) | (2,212,801 | ) | ||||
|
||||||||||||
Income Taxes |
250 | (253,785 | ) | 130 | (252,865 | ) | ||||||
|
||||||||||||
Net Loss Available to Common Shareholders |
$ | (263,191 | ) | $ | (568,931 | ) | $ | (633,911 | ) | $ | (1,959,936 | ) |
|
||||||||||||
Net Loss per Common Share |
||||||||||||
Basic |
$ | (0.05 | ) | $ | (0.11 | ) | $ | (0.12 | ) | $ | (0.38 | ) |
Diluted |
$ | (0.05 | ) | $ | (0.11 | ) | $ | (0.12 | ) | $ | (0.38 | ) |
Weighted Average Number of Common |
||||||||||||
Shares Outstanding |
||||||||||||
Basic |
5,200,623 | 5,200,623 | 5,200,623 | 5,200,623 | ||||||||
Diluted |
5,200,623 | 5,200,623 | 5,200,623 | 5,200,623 | ||||||||
|
||||||||||||
Comprehensive Loss |
||||||||||||
Net Loss |
$ | (263,191 | ) | $ | (568,931 | ) | $ | (633,911 | ) | $ | (1,959,936 | ) |
Other comprehensive loss, net of $-0- deferred income taxes in 2014 and 2013 |
||||||||||||
Foreign currency translation |
(102,235 | ) | (7,271 | ) | (93,180 | ) | (223,805 | ) | ||||
|
||||||||||||
Total Comprehensive Loss |
$ | (365,426 | ) | $ | (576,202 | ) | $ | (727,091 | ) | $ | (2,183,741 | ) |
See accompanying notes to consolidated financial statements
- 3 -
LEATT CORPORATION
CONSOLIDATED STATEMENT OF CHANGES
IN STOCKHOLDERS' EQUITY
AS OF AND FOR THE NINE
MONTHS ENDED SEPTEMBER 30, 2014
|
Accumulated | |||||||||||||||||||||||
|
Other | |||||||||||||||||||||||
|
Preferred Stock A | Common Stock | Additional | Comprehensive | Accumulated | |||||||||||||||||||
|
Shares | Amount | Shares | Amount | Paid - In Capital | Income (Loss) | Deficit | Total | ||||||||||||||||
|
||||||||||||||||||||||||
Balance, January 1, 2014 |
120,000 | $ | 3,000 | 5,200,623 | $ | 130,008 | $ | 7,307,515 | $ | (111,864 | ) | $ | (309,986 | ) | $ | 7,018,673 | ||||||||
|
||||||||||||||||||||||||
Compensation cost recognized in connection with stock options |
- | - | - | - | 2,427 | - | - | 2,427 | ||||||||||||||||
|
||||||||||||||||||||||||
Net loss |
- | - | - | - | - | - | (633,911 | ) | (633,911 | ) | ||||||||||||||
|
||||||||||||||||||||||||
Foreign currency translation adjustment |
- | - | - | - | - | (93,180 | ) | - | (93,180 | ) | ||||||||||||||
|
||||||||||||||||||||||||
Balance, September 30, 2014 |
120,000 | $ | 3,000 | 5,200,623 | $ | 130,008 | $ | 7,309,942 | $ | (205,044 | ) | $ | (943,897 | ) | $ | 6,294,009 |
See accompanying notes to consolidated financial statements
-4 -
LEATT CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2014 AND 2013
2014 | 2013 | |||||
Cash flows from operating activities |
||||||
Net loss |
$ | (633,911 | ) | $ | (1,959,936 | ) |
Adjustments to reconcile net loss to net cash provided by |
||||||
operating activities: |
||||||
Depreciation |
214,583 | 252,040 | ||||
Deferred income taxes |
(380 | ) | (254,870 | ) | ||
Stock-based compensation |
2,427 | - | ||||
Bad debt |
9,000 | - | ||||
Inventory reserve |
181,569 | - | ||||
Gain on sale of property and equipment |
(3,410 | ) | (2,844 | ) | ||
(Increase) decrease in: |
||||||
Accounts receivable |
1,665,497 | 1,960,807 | ||||
Inventory |
(45,399 | ) | 233,104 | |||
Payments in advance |
(250,937 | ) | 15,886 | |||
Prepaid expenses and other current assets |
710,333 | 738,340 | ||||
Income tax refunds receivable |
(25,000 | ) | - | |||
Other receivables |
90,000 | - | ||||
Deposits |
2,576 | 22,361 | ||||
Increase (decrease) in: |
||||||
Accounts payable and accrued expenses |
(893,082 | ) | (165,872 | ) | ||
Income taxes payable |
- | (1,499 | ) | |||
Net cash provided by operating activities |
1,023,866 | 837,517 | ||||
|
||||||
Cash flows from investing activities |
||||||
Capital expenditures |
(199,469 | ) | (236,131 | ) | ||
Proceeds from sale of property and equipment |
6,699 | 2,844 | ||||
Increase in short-term investments, net |
(17 | ) | (311 | ) | ||
Net cash used in investing activities |
(192,787 | ) | (233,598 | ) | ||
|
||||||
Cash flows from financing activities |
||||||
Repayments of short-term loan, net |
(797,548 | ) | (821,419 | ) | ||
Net cash used in financing activities |
(797,548 | ) | (821,419 | ) | ||
|
||||||
Effect of exchange rates on cash and cash equivalents |
(48,172 | ) | (80,224 | ) | ||
|
||||||
Net decrease in cash and cash equivalents |
(14,641 | ) | (297,724 | ) | ||
Cash and cash equivalents - beginning |
835,012 | 667,671 | ||||
Cash and cash equivalents - ending |
$ | 820,371 | $ | 369,947 | ||
|
||||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: |
||||||
Cash paid for interest |
$ | 11,818 | $ | 11,995 | ||
Cash paid for income taxes |
$ | 130 | $ | 2,419 | ||
|
||||||
Other noncash investing and financing activities |
||||||
Common stock issued for services |
$ | 2,427 | $ | - |
See accompanying notes to consolidated financial statements
- 5 -
LEATT CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (UNAUDITED)
Note 1 - Basis of presentation
The consolidated balance sheet as of December 31, 2013 was audited and appears in the Form 10-K filed by the Company with the Securities and Exchange Commission on March 19, 2014. The consolidated balance sheet as of September 30, 2014 and the consolidated statements of operations and comprehensive loss for the three months and nine months ended September 30, 2014 and 2013, changes in stockholders equity for the nine months ended September 30, 2014, cash flows for the nine months ended September 30, 2014 and 2013, and the related information contained in these notes have been prepared by management without audit. In the opinion of management, all adjustments (which include only normal recurring items) necessary to present fairly the financial position, results of operations and cash flows in conformity with generally accepted accounting principles as of September 30, 2014 and for all periods presented have been made. Interim operating results are not necessarily indicative of operating results for a full year.
Certain information and note disclosures normally included in the Companys annual financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted. While management of the Company believes that the disclosures presented are adequate to make the information not misleading, it is suggested that these condensed consolidated financial statements be read in conjunction with the audited financial statements and notes thereto for the year ended December 31, 2013 as filed with the Securities and Exchange Commission in the Companys Form 10-K.
Note 2 - Inventory
Inventory is stated at the lower of cost or market. Cost is determined using the first-in first-out (FIFO) method. Inventory consists primarily of finished goods. Shipping and handling costs are included in the cost of inventory. In assessing the inventory value, the Company must make estimates and judgments regarding reserves required for product obsolescence, aging of inventory and other issues potentially affecting the saleable condition of products. In performing such evaluations, the Company utilizes historical experience as well as current market information. The reserve for obsolescence for the nine months ended September 30, 2014 and 2013 was $313,224 and $0, respectively.
Note 3 - Intangible Assets
The Companys intangible assets consist of acquired patents with an indefinite useful life and are thus not amortized. Intangible assets are carried at cost less impairment. Amortization expense for the nine months ended September 30, 2014 was zero. There was no impairment of intangible assets at September 30, 2014.
Note 4 - Short-term Loan
The Company carries two product liability insurance policies one with a U.S. insurance carrier and a second with a South African insurance carrier. The Company finances payment of its short-term insurance premiums over the period of coverage, which is generally twelve months. The US short-term loan is payable in monthly installments of $68,274 over an 11 month period at an APR of 2.647% and the South African short-term loan is payable in monthly installments of $1,839 over a 10 month period at a flat interest rate of 3.50% .
The Company carries directors and officers liability insurance. The Company finances payment of its short-term insurance premiums over the period of coverage, which is generally twelve months. The short-term loan is payable in eleven payments of $4,997 at a 2.647% annual interest rate.
Note 5- Income Taxes
The Company uses the asset and liability approach to account for income taxes. Deferred tax assets and liabilities are determined based on the differences between the financial statement carrying amounts and the income tax basis of assets and liabilities. A valuation allowance is applied against any net deferred tax asset if, based on available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The provision for income taxes included taxes currently payable, if any, plus the net change during the period in deferred tax assets and liabilities recorded by the Company.
The Company applies the provisions of FASB ASC Topic 740-10, Accounting for Uncertainty in Income Taxes (Standard), which provides that the tax effects from an uncertain tax position can be recognized in the consolidated financial statements only if the position is more likely than not of being sustained upon an examination by tax authorities. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Additionally, the standard provides guidance on derecognition, classification, interest and penalties; accounting in interim periods, disclosure and transition, and any amounts when incurred would be recorded under these provisions.
- 9 -
The Companys practice is to recognize interest and/or penalties related to income tax matters in income tax expense. As of September 30, 2014, the Company has no unrecognized tax benefits. The Companys 2011 income tax return is under examination by the Internal Revenue Service.
Note 6 - Net Income Per Share of Common Stock
Basic net income per common share is computed using the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weightedaverage number of common stock shares and dilutive potential common shares outstanding during the period. For the three months and nine months ended September 30, 2014, the Company had 410,200 potential common shares, consisting of 120,000 preferred shares and options to purchase 290,200 shares, outstanding that were anti-dilutive and therefore not included in diluted net income per share.
Note 7 - Litigation
In the ordinary course of business, the Company is involved in various legal proceedings involving product liability and personal injury and intellectual property litigation. The Company is insured against loss for certain of these matters. The Company will record contingent liabilities resulting from asserted and unasserted claims against it when it is probable that the liability has been incurred and the amount of the loss is reasonably estimable. The Company will disclose contingent liabilities when there is a reasonable possibility that the ultimate loss will exceed the recorded liability. While the outcome of currently pending litigation is not yet determinable, the ultimate exposure with respect to these matters cannot be ascertained. However, based on the information currently available to the Company, the Company does not expect that any liabilities or costs that might be incurred to resolve these matters will have a material adverse effect on the financial condition, results of operations, liquidity or cash flows of the Company.
Note 8 Subsequent Events
The company has evaluated all subsequent events through the date the financial statements were released.
- 10 -
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
Special Note Regarding Forward Looking Statements
This report contains forward-looking statements that are contained principally in the sections entitled Our Business, Risk Factors, and Managements Discussion and Analysis of Financial Condition and Results of Operations. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These risks and uncertainties include, but are not limited to, the factors described in the section captioned Risk Factors in our latest annual report on Form 10-K filed with the SEC. In some cases, you can identify forward-looking statements by terms such as anticipates, believes, could, estimates, expects, intends, may, plans, potential, predicts, projects, should, would and similar expressions intended to identify forward-looking statements. Forward-looking statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking statements include, among other things, statements relating to:
- our expectations regarding growth in the motor sports market;
- our expectation regarding increasing demand for protective equipment used in the motor sports market;
- our belief that we will be able to effectively compete with our competitors and increase our market share;
- our expectations with respect to increased revenue growth and our ability to achieve profitability resulting from increases in our production volumes; and
- our future business development, results of operations and financial condition.
Also, forward-looking statements represent our estimates and assumptions only as of the date of this quarterly report. You should read this quarterly report and the documents that we reference and filed as exhibits to the quarterly report completely and with the understanding that our actual future results may be materially different from what we expect. Except as required by law, we assume no obligation to update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in any forward-looking statements, even if new information becomes available in the future.
Use of Certain Defined Terms
Except as otherwise indicated by the context, references in this quarterly report to:
- Leatt, we, us, our, the Registrant or the Company are to the combined business of Leatt Corporation, a Nevada corporation, its South African branch, Leatt SA, and its direct, wholly-owned subsidiaries, Two Eleven, Leatt New Zealand and Three Eleven;
- Leatt SA are to the Companys branch office known as Leatt Corporation (Incorporated in the State of Nevada) incorporated under the laws of South Africa with registration number: 2007/032780/10;
- Leatt USA are to Leatt USA, LLC, a Nevada Limited Liability Company;
- Leatt New Zealand are to Leatt New Zealand Limited, a New Zealand Company;
- NZD are to the legal currency of New Zealand. For all NZD amounts reported, the dollar amount has been calculated on the basis that $1=NZD1.28434 for its September 30, 2014 unaudited balance sheet.
- PRC, and China are to the Peoples Republic of China;
- Two Eleven refers to Two Eleven Distribution, LLC, a California limited liability company;
- Three Eleven are to Three Eleven Distribution (Pty) Limited, a South African Company;
- Securities Act are to the Securities Act of 1933, as amended, and to Exchange Act are to Securities Exchange Act of 1934, as amended;
- South Africa are to the Republic of South Africa;
- U.S. dollar, $ and US$ are to the legal currency of the United States.
- Xceed Holdings refers to Xceed Holdings cc., a close corporation incorporated under the laws of South Africa, and wholly-owned by The Leatt Family Trust, of which Dr. Christopher J. Leatt, the Companys chairman, is a Trustee and Beneficiary; and
- ZAR refers to the South African Rand, the legal currency of South Africa. For all ZAR dollar amounts reported, the dollar amount has been calculated on the basis that $1 = ZAR11.2594 for its September 30, 2014 unaudited balance sheet.
- 11 -
Overview
Leatt designs, develops, markets and distributes personal protective equipment for participants in all forms of motor sports and leisure activities, including riders of motorcycles, bicycles, snowmobiles and ATVs, as well as racing car drivers. The Company sells its products to customers worldwide through a global network of distributors and retailers. Leatt also acts as the original equipment manufacturer for neck braces sold by other international brands.
The Companys flagship products are based on the Leatt-Brace® system, a patented injection molded neck protection system owned by Xceed Holdings, designed to prevent potentially devastating injuries to the cervical spine and neck. The Company has the exclusive global manufacturing, distribution, sale and use rights to the Leatt-Brace®, pursuant to a license agreement between the Company and Xceed Holdings, a company owned and controlled by the Companys Chairman and founder, Dr. Christopher Leatt. The Company also has the right to use apparatus embodying, employing and containing the Leatt-Brace® technology and has designed, developed, marketed and distributed other personal protective equipment using this technology, as well as its own developed technology, including the Companys new body protection products which it markets under the Leatt Protection Range brand.
The Companys research and development efforts are conducted at its research facilities, located at its executive headquarters in Cape Town, South Africa. The Company employs 5 full-time employees who are dedicated exclusively to research, development, and testing. The Company also utilizes consultants, academic institutions and engineering companies as independent contractors or consultants, from time to time, to assist it with its research and development efforts. Leatt products have been tested and reviewed internally and by external bodies. All Leatt products are compliant with applicable European Union directives, or CE certified, where appropriate. Certain products, such as the Moto R, have been certified by SFI Foundation (USA) and the Moto GPX was tested by BMW Motorrad (Germany) and reviewed by KTM (Austria). The Company is also in discussions with governing and racing bodies, such as the Fédération Internationale de l'Automobile (FIA), the Fédération Internationale de Motocyclisme (FIM) and the National Association for Stock Car Auto Racing (NASCAR), to have the Leatt-Brace® accredited by these bodies.
Our products are manufactured in China under outsource manufacturing arrangements with third-party manufacturers located there. The Company utilizes outside consultants and its own employees to ensure the quality of its products through regular on-site product inspections. Products purchased through international sales are usually shipped directly from our manufacturers warehouses or points of dispatch to customers or their import agents.
Leatt earns revenues through the sale of its products through approximately 60 distributors worldwide, who in turn sell its products to retailers. Leatt distributors are required to follow certain standard business terms and guidelines for the sale and distribution of Leatt products. Two Eleven and Leatt SA directly distribute Leatt products to retailers in the United States and South Africa, respectively.
Principal Factors Affecting Our Financial Performance
We believe that the following factors will continue to affect our financial performance:
- Global Economic Fragility The ongoing turmoil in the
global economy, especially in the U.S. and Europe, may have an impact on our
business and our financial condition, and we may face challenges if economic
conditions do not improve. These economic conditions impact levels of consumer
spending, which have deteriorated and may remain depressed for the foreseeable
future. If demand for our products fluctuates as a result of these economic
conditions or otherwise, our revenue and gross margin could be harmed.
- Fuel Prices Significant fluctuations in fuel prices
could have both a positive and negative effect on our business and operations.
A significant portion of our revenue is derived from international sales and
significant fluctuations in world fuel prices could significantly increase the
price of shipping or transporting our products which we may not be able to
pass on to our customers. On the other hand, fluctuations in fuel prices lead
to higher commuter costs which may encourage the increased use of motorcycles
and bicycles as alternative modes of transportation and lead to an increase in
the market for our protection products.
- Product Liability Litigation We face an inherent business risk of exposure to product liability claims arising from the claimed failure of our products to help prevent the types of personal injury or death against which they are designed to help protect. Therefore we have acquired very costly product liability insurance worldwide. We have not experienced any material uninsured losses due to product liability claims, but it is possible that we could experience material losses in the future. After a two-week trial in the United States District Court for the Northern District of Ohio (Eastern) ending on April 17, 2014, a federal jury returned a defense verdict for the Company in the first Leatt-Brace® product liability lawsuit to be tried in the United States. The plaintiffs in that case had alleged that defective product design and failure to warn had caused a then fifteen year-old motocross rider, to suffer multiple mid-thoracic spine fractures, causing immediate and permanent paraplegia, when he crashed at a relatively low speed on February 13, 2011. When the accident occurred, he was wearing a helmet and other safety gear from several different companies, including the Company's acclaimed Leatt-Brace®. The Company produced evidence at trial showing that his thoracic paraplegia was an unavoidable consequence of his fall, not the result of wearing a Leatt-Brace®, and that the neck brace likely saved his life (or saved him from quadriplegia) by preventing cervical spine injury. The Company had maintained from the onset that this and a small handful of other lawsuits are without merit and that it will vigorously defend itself in each case. Although we carry product liability insurance, a successful claim brought against us could significantly harm our business and financial condition and have an adverse impact on our ability to renew our product liability insurance or secure new coverage.
- 12 -
- Protection of Intellectual Property We believe that the continued success of our business is dependent on our intellectual property portfolio consisting of globally registered trademarks, design patents and utility patents related to the Leatt-Brace®. We believe that a loss of these rights would harm or cause a material disruption to our business and, our corporate strategy is to aggressively take legal action against any violators of our intellectual property rights, regardless of where they may be. From time to time, we have had to enforce our intellectual property rights through litigation and we may be required to do so in the future. Such litigation may result in substantial costs and could divert resources and management attention from the operations of our business.
Results of Operations
The following summary of our results of operations should be read in conjunction with our financial statements and the notes thereto for the three-month and nine-month periods ended September 30, 2014 and 2013 included herein. The following tables set forth key components of our results of operations for the periods indicated, both in dollars and as a percentage of sales revenue and key components of our revenue for the periods indicated in dollars and percentages.
Three Months Ended September 30, 2014 compared to the Three Months Ended September 30, 2013
The following table summarizes the results of our operations during the three-month periods ended September 30, 2014 and 2013 and provides information regarding the dollar and percentage increase or (decrease) in such periods:
Percentage | ||||||||||||
Three Months Ended September 30, | $ Increase | Increase | ||||||||||
Item | 2014 | 2013 | (Decrease) | (Decrease) | ||||||||
REVENUES | $ | 3,468,761 | $ | 2,243,598 | $ | 1,225,163 | 55% | |||||
COST OF REVENUES | 1,584,460 | 1,071,522 | $ | 512,938 | 48% | |||||||
GROSS PROFIT | 1,884,301 | 1,172,076 | $ | 712,225 | 61% | |||||||
PRODUCT ROYALTY INCOME | 65,083 | 105,328 | $ | (40,245 | ) | -38% | ||||||
OPERATING EXPENSES | ||||||||||||
Salaries and Wages | 547,955 | 508,641 | $ | 39,314 | 8% | |||||||
Commissions and Consulting | 134,692 | 142,866 | $ | (8,174 | ) | -6% | ||||||
Professional Fees | 209,168 | 197,672 | $ | 11,496 | 6% | |||||||
Advertising and Marketing | 320,449 | 339,578 | $ | (19,129 | ) | -6% | ||||||
Office Rent and Expenses | 61,807 | 62,528 | $ | (721 | ) | -1% | ||||||
Research and Development Costs | 288,904 | 274,218 | $ | 14,686 | 5% | |||||||
General and Administrative | 565,004 | 518,537 | $ | 46,467 | 9% | |||||||
Bad debt expense | 16,357 | - | $ | 16,357 | 100% | |||||||
Depreciation | 67,075 | 60,585 | $ | 6,490 | 11% | |||||||
Total Operating Expenses | 2,211,411 | 2,104,625 | $ | 106,786 | 5% | |||||||
LOSS FROM OPERATIONS | (262,027 | ) | (827,221 | ) | $ | 565,194 | 68% | |||||
Other Income (Expense) | (914 | ) | 4,505 | $ | (5,419 | ) |
-120% |
|||||
LOSS BEFORE INCOME TAXES | (262,941 | ) | (822,716 | ) | $ | 559,775 | 68% | |||||
Income Taxes | 250 | (253,785 | ) | $ | 254,035 | 100% | ||||||
NET LOSS | $ | (263,191 | ) | $ | (568,931 | ) | $ | 305,740 | 54% |
- 13 -
Revenues We earn revenues from the sale of our protective gear comprising of Neck Braces, Body Armor and Other Products, Parts and Accessories both in the United States and internationally. For the three months ended September 30, 2014 and 2013, revenues associated with international customers were $2.13 million and $1.18 million, or 61% and 53% of revenues, respectively. Revenues for the three months ended September 30, 2014 were $3.47 million, a 55% increase, compared to revenues of $2.24 million for the quarter ended September 30, 2013. This increase in revenues is attributable to a $0.30 million increase in Neck Brace sales, as well as a $1.0 million increase in Body Armor sales.
The following table sets forth our revenues by product line for the three months ended September 30, 2014 and 2013:
Three Months Ended September 30, | ||||||||||||
2014 | % of | 2013 | % of | |||||||||
Revenues | Revenues | |||||||||||
Neck Braces | $ | 1,618,544 | 47% | $ | 1,321,626 | 59% | ||||||
Body Armor | $ | 1,716,500 | 49% | $ | 719,929 | 32% | ||||||
Other Products, Parts and Accessories | $ | 133,717 | 4% | $ | 202,043 | 9% | ||||||
$ | 3,468,761 | 100% | $ | 2,243,598 | 100% |
Sales of our flagship Neck Brace accounted for $1.62 million and $1.32 million, or 47% and 59% of our revenues for the quarters ended September 30, 2014 and 2013, respectively. The 23% increase in Neck Brace revenues in the United States is primarily attributable to increased demand for the Companys Neck Brace products as a result of the introduction of the Fusion 2.0 Junior and 5.5 Neck Brace product lines in the United States and abroad.
Our Body Armor products are comprised of chest protectors, full upper body protectors, upper body protection vests, back protectors, knee braces and knee and elbow guards. Body Armor sales accounted for $1.72 million and $0.72 million or 49% and 32% of our revenues for the quarters ended September 30, 2014 and 2013, respectively. The 139% increase in Body Armor revenues was primarily the result of successful market acceptance of our new C Frame Knee Brace which was introduced during the 2014 period.
Our Other Products, Parts and Accessories are comprised of aftermarket support items required primarily to replace worn or damaged parts through our global distribution network as well as clothing, outerwear and accessories that include hats, jackets, bags, hydration kits and cooling garments. Other Products, Parts and Accessories sales accounted for $0.1 million and $0.2 million or 4% and 9% of our revenues for the quarters ended September 30, 2014 and 2013, respectively. The decrease in our Other Products, Parts and Accessories is primarily due to a 62% decrease in the volume of hydration units sold internationally during the period.
Cost of Revenues and Gross Profit Cost of revenues for the quarters ended September 30, 2014 and 2013 were $1.6 million and $1.1 million, respectively. Gross Profit for the quarters ended September 30, 2014 and 2013 were $1.9 million and $1.2 million, respectively, or 54% and 52% of revenues respectively. The increase in gross profit margin was primarily due to increased Neck Brace sales in the United States and abroad, as well as improved Body Armor margins as a result of the introduction of the C Frame Knee Guard during the 2014 period. While our Body Armor products continue to generate a lower gross margin than do Neck Brace products, they represented 49% of the total Company sales in the third quarter of 2014, as compared to only 32% in the third quarter of 2013.
Product Royalty Income Product royalty income is earned on sales to distributors that have royalty agreements in place, as well as sales of licensed products by third parties that have licensing agreements in place. Product royalty income for the quarters ended September 30, 2014 and 2013 were $65,083 and $105,328, respectively. The 38% decrease in product royalty income is due to a decrease in the sale of licensed products by licensees in the 2014 period.
Salaries and Wages Salaries and wages for the quarters ended September 30, 2014 and 2013 were $547,955 and $508,641, respectively. This 8% increase in salaries and wages during the 2014 period was primarily due to the employment of additional US sales management and European brand management staff.
- 14 -
Commissions and Consulting Expense During the quarters ended September 30, 2014 and 2013, commissions and consulting expenses were $134,692 and $142,866, respectively. This 6% decrease in commissions and consulting expenses is primarily due to the restructuring of remuneration packages for US sales staff.
Professional Fees Professional fees consist of costs incurred for audit, tax and regulatory filings, as well as patent protection and product liability litigation expenses incurred as the Company continues to expand. Professional fees for the quarters ended September 30, 2014 and 2013 were $209,168 and $197,672, respectively. This 6% increase in professional fees is primarily due to increased spending on product liability litigation during the 2014 period.
Advertising and Marketing The Company places paid advertising in various motorsport magazines and online media, and sponsors a number of events, teams and individuals to increase product and brand visibility. Advertising and marketing expenses for the quarters ended September 30, 2014 and 2013 were $320,449 and $339,578, respectively. The 6% decrease in advertising and marketing expenditures during the 2014 period is primarily due to the Companys continued expansion of more cost effective online marketing campaigns that reach a wider audience than the print campaigns previously utilized by the Company.
Office Rent and Expenses Office rent and expenses for the quarters ended September 30, 2014 and 2013 remained flat at $61,807 and $62,528, respectively.
Research and Development Costs These costs consists of the salaries of staff members that are directly involved in the research and development of innovative products, as well as the direct costs associated with developing these products. Research and development costs for the quarters ended September 30, 2014 and 2013, increased to $288,904, from $274,218, during the same 2013 quarter. The 5% increase in research and development costs is a result of direct costs incurred in the continued development of the Companys widening range of innovative products.
General and Administrative Expenses General and administrative expenses consists of insurance, travel, merchant fees, telephone, office and computer supplies. General and administrative expenses for the quarters ended September 30, 2014 and 2013 were $565,004 and $518,537, respectively. The 9% increase in general and administrative expenses is primarily as a result of increased travel expenditures incurred by the Companys research and development staff during the 2014 period.
Bad Debt Expense Bad Debt Expense for the quarters ended September 30, 2014 and 2013 were $16,357 and $0, respectively. This 100% increase in Bad Debt Expense is primarily the result of the write off of a portion of unrecoverable debt owing to Two Eleven.
Depreciation Expense Depreciation Expense for the quarters ended September 30, 2014 and 2013 were $67,075 and $60,585, respectively. This 11% increase in depreciation is primarily as a result of the addition of molds and tooling required for the production of the Companys widening product range.
Total Operating Expenses Total operating expenses increased by $106,786, to $2,211,411 in the three months ended September 30, 2014, or 5%, compared to $2,104,625 in the 2013 period. This increase is primarily due to the increased salaries, wages and general administrative expenditures discussed above.
Net loss The net loss after income taxes for the quarter ended September 30, 2014 was $263,191 as opposed to net loss after income taxes of $568,931 for the quarter ended September 30, 2013. This decrease in net loss is primarily due to increased revenues and decreased cost of revenues that were partially offset by increased operating costs discussed above.
Nine Months Ended September 30, 2014, compared to the Nine Months Ended September 30, 2013
The following table summarizes the results of our operations during the nine-month periods ended September 30, 2014 and 2013 and provides information regarding the dollar and percentage increase or (decrease) in such periods:
- 15 -
Percentage | ||||||||||||
Nine Months Ended September 30, | $ Increase | Increase | ||||||||||
Item | 2014 | 2013 | (Decrease) | (Decrease) | ||||||||
REVENUES | $ | 11,159,630 | $ | 9,108,243 | $ | 2,051,387 | 23% | |||||
COST OF REVENUES | 5,070,624 | 4,555,276 | $ | 515,348 | 11% | |||||||
GROSS PROFIT | 6,089,006 | 4,552,967 | $ | 1,536,039 | 34% | |||||||
PRODUCT ROYALTY INCOME | 136,346 | 285,014 | $ | (148,668 | ) | -52% | ||||||
OPERATING EXPENSES | ||||||||||||
Salaries and Wages | 1,651,178 | 1,640,282 | $ | 10,896 | 1% | |||||||
Commissions and Consulting | 441,943 | 426,035 | $ | 15,908 | 4% | |||||||
Professional Fees | 823,690 | 1,013,783 | $ | (190,093 | ) | -19% | ||||||
Advertising and Marketing | 995,502 | 1,069,903 | $ | (74,401 | ) | -7% | ||||||
Office Rent and Expenses | 183,792 | 195,342 | $ | (11,550 | ) | -6% | ||||||
Research and Development Costs | 903,231 | 839,823 | $ | 63,408 | 8% | |||||||
General and Administrative | 1,611,242 | 1,619,221 | $ | (7,979 | ) | 0% | ||||||
Bad debt expense | 38,652 | - | $ | 38,652 | 100% | |||||||
Depreciation | 214,583 | 252,040 | $ | (37,457 | ) | -15% | ||||||
Total Operating Expenses | 6,863,813 | 7,056,429 | $ | (192,616 | ) | -3% | ||||||
LOSS FROM OPERATIONS | (638,461 | ) | (2,218,448 | ) | $ | 1,579,987 | 71% | |||||
Other Income | 4,680 | 5,647 | $ | (967 | ) | -17% | ||||||
LOSS BEFORE INCOME TAXES | (633,781 | ) | (2,212,801 | ) | $ | 1,579,020 | 71% | |||||
Income Taxes | 130 | (252,865 | ) | $ | 252,995 | 100% | ||||||
NET LOSS | $ | (633,911 | ) | $ | (1,959,936 | ) | $ | 1,326,025 | 68% |
Revenues Revenues for the nine months ended September 30, 2014 were $11.16 million, a 23% increase, compared to revenues of $9.11 million for the nine-month period ended September 30, 2013. Revenues associated with international customers were $6.46 million and $5.13 million, or 58% and 56% of revenues, respectively, for the 2014 and 2013 periods. The overall increase in revenues is attributable to a $1.25 million increase in Neck Brace sales, as well as a $0.87 million increase in Body Armor sales during the 2014 period.
The following table sets forth our revenues by product line for the nine months ended September 30, 2014 and 2013:
Nine Months Ended September 30, | ||||||||||||
2014 | % of | 2013 | % of | |||||||||
Revenues | Revenues | |||||||||||
Neck Braces | $ | 6,123,098 | 55% | $ | 4,873,332 | 54% | ||||||
Body Armor | $ | 4,507,136 | 40% | $ | 3,635,921 | 40% | ||||||
Other Products, Parts and Accessories | $ | 529,396 | 5% | $ | 598,990 | 6% | ||||||
$ | 11,159,630 | 100% | $ | 9,108,243 | 100% |
Sales of our flagship Neck Brace accounted for $6.1 million and $4.9 million, or 55% and 54% of our revenues for the nine-month periods ended September 30, 2014 and 2013, respectively. The 26% increase in Neck Brace revenues in the United States is primarily a result of the successful market acceptance of the Fusion 2.0 Junior and 5.5 Neck Brace in the United States and abroad. Neck Brace revenues were also higher in the 2014 period due to the sale of newly released products at full value, as compared to the sale of older Brace products at lower close out prices in the prior year period.
Body Armor sales accounted for $4.5 million and $3.6 million, or 40% and 40% of our revenues for the nine-month periods ended September 30, 2014 and 2013, respectively. The 24% increase in Body Armor revenues was primarily due to the successful acceptance of the Companys new C Frame Knee Brace internationally.
Other Products, Parts and Accessories sales accounted for $0.53 million and $0.59 million, or 5% and 6% of our revenues for the nine-month periods ended September 30, 2014 and 2013, respectively. The decrease in our Other Products, Parts and Accessories is primarily due to a 31% decrease in the volume of hydration units sold during the period, when compared to the prior year period.
Cost of Revenues and Gross Profit Cost of revenues for the nine-month periods ended September 30, 2014 and 2013 were $5.1 million and $4.6 million, respectively. Gross Profit for the nine-month periods ended September 30, 2014 and 2013 were $6.1 million and $4.6 million, respectively, or 55% and 50% of revenues respectively. The increase in gross profit margin was primarily due to increased Neck Brace sales in the United States and abroad, as well as improved Body Armor margins as a result of the introduction of the C Frame Knee Brace. Our Body Armor products continue to generate a lower gross margin than do Neck Brace products.
- 16 -
Product Royalty Income – Product royalty income for the nine months ended September 30, 2014 and 2013 were $136,346 and $285,014, respectively. The 52% decrease in product royalty income is due to a decrease in the sale of licensed products by licensees in the 2014 period.
Salaries and Wages – Salaries and wages for the nine-month periods ended September 30, 2014 and 2013 were $1,651,178 and $1,640,282, respectively. This 1% increase in salaries and wages is primarily due to the employment of new US sales management staff, as well as the restructuring of remuneration packages for US sales staff.
Commissions and Consulting Expense – During the nine-month periods ended September 30, 2014 and 2013, commissions and consulting expenses were $441,943 and $426,035, respectively. This 4% increase in commissions and consulting expenses is primarily due to increased commissions payable to the Company’s European sales staff, compared to the prior period.
Professional Fees – Professional fees for the nine-month periods ended September 30, 2014 and 2013 were $823,690 and $1,013,783, respectively. This 19% decrease in professional fees during the 2014 period is primarily due to decreased spending on patent litigation during the 2014 period. The Company settled various patent infringement suits during the period ended December 31, 2013.
Advertising and Marketing – Advertising and marketing expenses for the nine-month periods ended September 30, 2014 and 2013 were $995,502 and $1,069,903, respectively. The 7% decrease in advertising and marketing expenditures during the 2014 period is primarily due to the Company’s continued focus on more cost effective online and digital campaigns that reach a wider audience than the print campaigns previously utilized by the Company.
Office Rent and Expenses – Office rent and expenses for the nine-month periods ended September 30, 2014 and 2013 were $183,792 and $195,342, respectively. The 6% decrease in office rent and expenses is primarily the result of the consolidation of offsite additional warehouse space that was previously occupied by Two Eleven.
Research and Development Costs – Research and development costs for the nine-month periods ended September 30, 2014 and 2013, increased to $903,231, from $839,823, respectively. The 8% increase in research and development costs is a result of development costs incurred to widen the Company’s range of innovative protective gear.
Bad Debt Expense – Bad Debt Expense for the nine-month periods ended September 30, 2014 and 2013 were $38,652 and $0, respectively. This 100% increase in Bad Debt Expense is due to the write off of debt owing by US customers that were deemed to be irrecoverable.
General and Administrative Expenses – General and administrative expenses for the nine-month periods ended September 30, 2014 and 2013 were $1,611,242 and $1,619,221, respectively. The 0.5% decrease in general and administrative expenses is primarily as a result of decreased expenditures on telecommunication costs.
Depreciation Expense – Depreciation Expense for the nine-month periods ended September 30, 2014 and 2013 were $214,583 and $252,040, respectively. This 15% decrease in depreciation is primarily as a result of various assets being fully depreciated for the period having reached the end of their economic useful lives.
Total Operating Expenses – Total operating expenses decreased by $192,616 to $6,863,813 in the nine months ended September 30, 2014, or 3%, compared to $7,056,429 in the 2013 period. This decrease is primarily due to decreased spending of professional fees relating to patent litigation discussed above.
Net loss –The net loss after income taxes for the nine-month period ended September 30, 2014 was $633,911, as compared to net loss after income taxes of $1,959,936 for the same 2013 period. This decrease in net loss is primarily due to increased revenues and decreased cost of revenues, as well as decreased operating expenses discussed above.
- 17 -
Liquidity and Capital Resources
At September 30, 2014, we had cash and cash equivalents of $0.8 million and $0.06 million of short-term investments. The following table sets forth a summary of our cash flows for the periods indicated:
September 30, | ||||||
2014 | 2013 | |||||
Net cash provided by operating activities | $ | 1,023,866 | $ | 837,517 | ||
Net cash used in investing activities | $ | (192,787 | ) | $ | (233,598 | ) |
Net cash used in financing activities | $ | (797,548 | ) | $ | (821,419 | ) |
Effect of exchange rate changes on cash and cash equivalents | $ | (48,172 | ) | $ | (80,224 | ) |
Net (decrease) in cash and cash equivalents | $ | (14,641 | ) | $ | (297,724 | ) |
Cash and cash equivalents at the beginning of period | $ | 835,012 | $ | 667,671 | ||
Cash and cash equivalents at the end of period | $ | 820,371 | $ | 369,947 |
Cash decreased by $14,641, or 2%, for the nine months ended September 30, 2014. The primary sources of cash for the nine months ended September 30, 2014 were decreased accounts receivables of $1,665,497, and decreased prepaid expenses and other current assets of $710,333. The primary uses of cash for the nine months ended September 30, 2014 was a net loss of $633,911, decreased accounts payable and accrued expenses of $893,082 and the repayment of a short-term loan amounting to $797,548. As of September 30, 2014, we did not have any credit facilities or significant amounts owed to third party lenders.
The Company is currently meeting its working capital needs through cash on hand as well as internally generated cash from operations. Management believes that its current cash and cash equivalent balances, along with the net cash generated by operations are sufficient to meet its anticipated operating cash requirements for at least the next twelve months. There are currently no plans for any major capital expenditures in the next twelve months. Our long-term financing requirements depend on our growth strategy, which relates primarily to our desire to increase revenue both domestically as well as internationally.
Obligations under Material Contracts
Pursuant to our Licensing Agreement with Xceed Holdings, a company owned and controlled by Dr. Christopher Leatt, our founder, chairman and head of research and development, we pay Xceed Holdings, 4% of all Neck Brace sales revenue billed and received by the Company on a quarterly basis, based on sales of the previous quarter. In addition, pursuant to a separate license agreement between the Company and Mr. J. P. De Villiers, our former director, the Company is obligated to pay a royalty fee of 1% of all our billed and received Neck Brace sales revenue, in quarterly installments, based on sales of the previous quarter, to a trust that is beneficially owned and controlled by Mr. De Villiers.
Pursuant to a Premium Finance Agreement, dated October 11, 2013, between the Company and AFCO Acceptance Corporation AFCO, the company was obligated to pay AFCO an aggregate sum of $1,001,151 in eleven payments of $91,014, at a 2.647% annual interest rate, commencing on November 1, 2013 and ending on September 1, 2014. As of September 30, 2014, the Company had repaid AFCO the entire balance due under the Premium Finance Agreement, and had entered into a new premium financing agreement, dated October 7, 2014, with them. Pursuant to the new agreement, the Company is obligated to pay AFCO an aggregate sum of $741,165 in eleven payments of $68,273, at an annual interest rate of 2.647%, commencing on November 1, 2014 and ending on September 1, 2015. Any late payment during the term of the agreement will be assessed a late penalty of 5% of the payment amount due, and in the event of default AFCO has the right to accelerate the payment due under the agreement.
Pursuant to a Premium Finance Agreement, dated June 9, 2014, between the Company and AFCO, the company is obligated to pay AFCO an aggregate sum of $59,244 in eleven payments of $4,997 at a 2.647% annual interest rate, commencing on June 1, 2014 and ending on April 1, 2015. Any late payment during the term of the agreement will be assessed a late penalty of 5% of the payment amount due, and in the event of default AFCO has the right to accelerate the payment due under the agreement. As of September 30, 2014, the Company had not defaulted on its payment obligations under this agreement.
- 18 -
Critical Accounting Policies and Estimates
Our discussion and analysis of financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported revenues and expenses during the reporting period.
There have been no material changes in our critical accounting policies or critical accounting estimates since December 31, 2013. We have not adopted any accounting policies since December 31, 2013 that have or will have a material impact on our consolidated financial statements. For further discussion of our accounting policies see the “Summary of Significant Accounting Policies” in the Notes to Consolidated Financial Statements, as of and for the year ended December 31, 2013 included in our annual report on Form 10-K filed for the period, as well as the notes in this Form 10-Q.
We have identified the following as the items that require the most significant judgment and often involve complex estimation: revenue recognition, estimating allowances for doubtful accounts receivable, inventory valuation, impairment of long-lived assets and accounting for income taxes.
Revenue and Cost Recognition - All manufacturing of Leatt products is performed by third party subcontractors in China. The Company's products are sold worldwide to a global network of distributors and dealers, and directly to consumers when there are no dealers or distributors in their geographic area (collectively the "customers"). Revenues from product sales are recognized when earned, net of applicable provisions for discounts and returns and allowances in the event of product defect. Revenue is considered to be realized or realizable and earned when all of the following criteria are met: title and risk of loss have passed to the customer, persuasive evidence of an arrangement exists, delivery has occurred, the price is fixed and determinable and collectability is reasonably assured. Our distributor payment terms range from pre-payment in full to 60 days after shipment and subsequent sales of our products by distributors have no effect on the amount and timing of payments due to us. Furthermore, products purchased by distributors may not be returned to us in the event that any such distributor relationship is terminated.
Since the Company (through its wholly owned subsidiary) serves as the distributor of Leatt products in the United States, the Company records its revenue and related cost of revenue for its product sales in the United States upon shipment of the merchandise to the dealer or to the ultimate consumer when there is no dealer in the geographic area and the sales order was received directly from, and paid by, the ultimate consumer. Since the Company (through its South African branch) serves as the distributor of Leatt products in South Africa, the Company records its revenue and related cost of revenue for its product sales in South Africa upon shipment of the merchandise from the branch to the dealer. International sales (other than in South Africa) are generally drop-shipped directly from the third party manufacturer to the international distributors.
Revenue and related cost of revenue is recognized at the time of shipment from the manufacturer's port when the shipping terms are Free On Board ("FOB") shipping point, Cost and Freight ("CFR") or Cost and Insurance to named place ("CIP") as legal title and risk of loss to the product pass to the distributor. Sales to all customers (distributors, dealers and consumers) are generally final; however, in limited instances, product may be returned due to product quality issues. Historically, returns due to product quality issues have not been material and there have been no distributor terminations that resulted in product returns. Cost of revenues also includes royalty fees associated with sales of Leatt-Brace products.
Product royalty income is recorded as the underlying product sales occur, in accordance with the related licensing arrangements.
Allowance for Doubtful Accounts Receivable – Accounts receivable consist of amounts due to the Company from normal business activities. Credit is granted to substantially all distributors on an unsecured basis. We continuously monitor collections and payments from customers and maintain an allowance for doubtful accounts receivable based upon historical experience and any specific customer collection issues that have been identified. In determining the amount of the allowance, we are required to make certain estimates and assumptions. Accounts receivable balances that are still outstanding after we have used reasonable collection efforts are written off as uncollectible. While such credit losses have historically been minimal, within our expectations and the provisions established, we cannot guarantee that we will continue to experience the same credit loss rates that we have in the past. A significant change in the liquidity or financial position of any of our significant customers could have a material adverse effect on the collectability of our accounts receivable and our future operating results.
Inventory Valuation Inventory is stated at the lower of cost or market. Cost is determined using the first-in first-out (FIFO) method. Inventory consists primarily of finished goods. Shipping and handling costs are included in the cost of inventory. In assessing the inventory value, we make estimates and judgments regarding reserves required for product obsolescence, aging of inventory and other issues potentially affecting the saleable condition of products. In performing such evaluations, we utilize historical experience as well as current market information. The reserve for obsolescence was $313,224 and $0 as of September 30, 2014 and 2013, respectively. The addition to the reserve was $16,404 and $0 for the quarters ended September 30, 2014 and 2013, respectively.
- 19 -
Impairment of Long-Lived Assets – Our long-lived assets include property and equipment. We evaluate our long-lived assets for recoverability whenever events or changes in circumstances indicate that an asset may be impaired. In evaluating an asset for recoverability, we estimate the future cash flow expected to result from the use of the asset and eventual disposition. If the expected future undiscounted cash flow is less than the carrying amount of the asset, an impairment loss, equal to the excess of the carrying amount over the fair value of the asset, is recognized. We have determined there was no impairment charge during the quarters ended September 30, 2014 and 2013.
Income Taxes – As part of the process of preparing our consolidated financial statements, we are required to estimate our income tax provision (benefit) in each of the jurisdictions in which we operate. This process involves estimating our current income tax provision (benefit) together with assessing temporary differences resulting from differing treatment of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are included within our consolidated balance sheets. We regularly evaluate our ability to recover the reported amount of our deferred income taxes considering several factors, including our estimate of the likelihood of the Company generating sufficient taxable income in future years during the period over which the temporary differences reverse.
Recent Accounting Pronouncements
In April 2014, the Financial Accounting Standards Board ("FASB") issued an accounting standards update providing new guidance on the requirements for reporting a discontinued operation. The new guidance changes the criteria for reporting discontinued operations and enhances the reporting requirements for discontinued operations. Under the new guidance, a discontinued operation must represent a strategic shift that has or will have a major effect on an entity's operations and financial results. The revised standard will allow an entity to have certain continuing cash flows or involvement with the component after the disposal, and requires expanded disclosures. The standard is effective for reporting periods beginning after December 15, 2014. Management does not anticipate that the adoption of this standard will have a significant impact on the Company's consolidated financial statements.
In May 2014, the FASB issued a comprehensive new standard which amends revenue recognition principles and provides a single set of criteria for revenue recognition among all industries. The new standard provides a five step framework whereby revenue is recognized when promised goods or services are transferred to a customer at an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard also requires enhanced disclosures pertaining to revenue recognition in both interim and annual periods. The standard is effective for interim and annual periods beginning after December 15, 2016 and allows for adoption using a full retrospective method, or a modified retrospective method. Management has not yet assessed the method of adoption or the expected impact the new standard will have on the Company's consolidated financial statements.
In August 2014, the FASB issued new guidance regarding the Company's responsibility for disclosure of uncertainties about an entity's ability to continue as a going concern. Management will be required to evaluate whether there are conditions and events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the financial statements are issued, and, if so, disclose that fact. Management will be required to make this evaluation for both annual and interim reporting periods, if applicable. The standard is effective for annual periods ending after December 15, 2016 and interim periods ending after December 15, 2016. Management does not anticipate that the adoption of this standard will significantly impact the Company's consolidated financial statements.
The Company does not believe there are any other recent accounting pronouncements that would have a material impact on its financial position or results of operations.
Inflation
Inflationary factors such as increases in the cost of our sales and overhead costs may adversely affect our operating results. Although we do not believe that inflation has had a material impact on our financial position or results of operations to date, a high rate of inflation in the future may have an adverse effect on our ability to maintain current levels of gross margin and selling, general and administrative expenses as a percentage of net sales if the selling prices of our products do not increase with these increased costs.
- 20 -
Off-Balance Sheet Arrangements
As of September 30, 2014, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on its financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to its stockholders.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
Not Applicable.
ITEM 4. CONTROLS AND PROCEDURES.
Disclosure Controls and Procedures
As of September 30, 2014, the Company’s management, under the direction of its Chief Executive Officer and the Chief Financial Officer, Mr. Sean Macdonald, carried out an evaluation of the effectiveness of the design and operation of the disclosure controls and procedures pursuant to Exchange Act Rule 13a-15. Our disclosure controls and procedures are designed to provide reasonable assurance that the information required to be disclosed in our SEC reports is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms, and is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based upon that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer determined that the Company’s disclosure controls and procedures were deemed to be effective.
Changes in Internal Controls over Financial Reporting
There were no changes in our internal controls over financial reporting during the period ended September 30, 2014, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II
OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.
From time to time, we may become involved in various lawsuits and legal proceedings in the ordinary course of our business. Other than as set forth below, we are currently not aware of any legal proceedings the ultimate outcome of which, in our judgment based on information currently available, would have a material adverse affect on our business, financial condition or operating results.
-
On December 30, 2011, a motorcycle rider brought suit against the Company in the United States District Court for the Northern District of Ohio (Eastern Division) for alleged breach of warranty and product liability claims in connection with injury
allegedly suffered by him during an October 2011 accident while wearing one of the Company’s products. The plaintiff is seeking damages in excess of $75,000 for compensatory and punitive damages together with interest and costs of bringing
the action. This matter has been settled.
- In February 2012, Scott Scarvelli, a motorcycle rider, and his parents, brought suit against the Company in the United States District Court for the Northern District of Ohio (Eastern Division) for alleged breach of warranty and product liability claims. The Scarvellis had alleged that defective product design and failure to warn had caused the then fifteen year-old Scott, to suffer multiple mid-thoracic spine fractures, causing immediate and permanent paraplegia, when he crashed at a relatively low speed on February 13, 2011. When the accident occurred, he was wearing a helmet and other safety gear from several different companies, including the Company's acclaimed Leatt-Brace®. The plaintiffs were seeking damages in excess of $75,000 for compensatory and punitive damages together with interest and costs of bringing the action. However, the Company produced evidence at trial showing that Scott’s thoracic paraplegia was an unavoidable consequence of his fall, not the result of wearing a Leatt-Brace®, and that the neck brace likely saved his life—or saved him from quadriplegia—by preventing cervical spine injury. After a two-week trial ending on April 17, 2014, a federal jury returned a defense verdict for the Company. This matter has been settled.
- 21 -
- On July 24, 2012, a motorcycle rider brought suit against the Company in
Los Angeles (CA) Superior Court for alleged negligence, strict product
liability, breach of expressed and implied warranties in connection with
injury allegedly suffered by him during a September 2010 accident while
wearing one of the Companys products. The plaintiff is seeking damages,
together with interest and costs of bringing the action. Trial is currently
scheduled to commence January 21, 2015. The Company believes that the lawsuit
is without merit and will vigorously defend itself.
- In September 20, 2012, a lawsuit was filed against the Company and other
Defendants in Clark County District Court of Nevada for wrongful death of a
motorcycle rider for alleged negligence, product defect, strict product
liability, breach of expressed and implied warranties, survival and punitive
damages. The plaintiff is seeking special, compensatory, survival and punitive
damages, together with prejudgment interest, costs and disbursement of suit,
reasonable attorneys fees and other relief. Trial is currently scheduled to
commence on January 11, 2016. The Company believes that the lawsuit is without
merit and will vigorously defend itself.
- On December 28, 2012, a lawsuit was filed against the Company in Los
Angeles Superior Court for wrongful death of a motorcycle rider. The
plaintiffs are seeking damages for wrongful death and other relief. The case
was timely removed to federal court. Trial is currently scheduled to commence
on May 5, 2015. The Company believes that the lawsuit is without merit and
will vigorously defend itself.
- In February 2013, a lawsuit was filed against the Company on behalf of a motorcycle rider in Clark County District Court of Nevada for alleged product defect, failure to warn and negligence. The plaintiff is seeking damages, together with interest and costs of bringing the action. Trial is currently scheduled to commence August 3, 2015. The Company believes that the lawsuit is without merit and will vigorously defend itself.
ITEM 1A. RISK FACTORS.
There are no material changes from the risk factors previously disclosed in Item 1A Risk Factors of our annual report on Form 10-K for the period ended December 31, 2013.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
None.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES.
None.
ITEM 4. MINE SAFETY DISCLOSURES.
None.
ITEM 5. OTHER INFORMATION.
We have no information to disclose that was required to be in a report on Form 8-K during the period covered by this report, but was not reported. There have been no material changes to the procedures by which security holders may recommend nominees to our board of directors.
- 22 -
ITEM 6. EXHIBITS.
The following exhibits are filed as part of this report or
incorporated by reference:
* |
Filed with this Form 10-Q for Leatt Corporation. Pursuant to Rule 406T of Regulation S-T, the interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, or for purposes of Section 18 of the Securities Act of 1934, as amended, and otherwise are not subject to liability under those sections. |
- 23 -
SIGNATURES
In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: November 13, 2014 | LEATT CORPORATION |
By: /s/ Sean Macdonald | |
Sean Macdonald | |
Chief Executive Officer and Chief Financial Officer | |
(Principal Executive, Financial and Accounting Officer) |
- 24 -
EXHIBIT INDEX
* |
Filed with this Form 10-Q for Leatt Corporation. Pursuant to Rule 406T of Regulation S-T, the interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, or for purposes of Section 18 of the Securities Act of 1934, as amended, and otherwise are not subject to liability under those sections. |